01.02.2017
- Novo Nordisk has announced plans to invest 1 billion Danish kroner ($145 million) over 10 years in a new research center at the University of Oxford, giving a major boost to the UK...
15.12.2016
- Johnson & Johnson has withdrawn from the running for Actelion Pharmaceuticals, leaving the path clear for another buyer, which multiple reports say is Sanofi. The US healthcare...
13.09.2016
- French drugmaker Sanofi and US-based Verily Life Sciences (formerly Google Life Sciences) have launched a joint-venture company, Onduo, in a bid to improve patients’ management of...
04.04.2016
- Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...
08.12.2015
- US drugmaker Eli Lilly is ending development of its injectable basal insulin peglispro (BIL), a potential treatment for type 1 and type 2 diabetes, to focus on other, more...
17.11.2015
- US-based drugs firm Janssen Pharmaceuticals has gained worldwide rights, excluding China and Korea, to develop and commercialize oxyntomodulin-based treatments for diabetes and...
13.11.2015
- French drugmaker Sanofi has entered into two separate collaborations to develop and commercialize diabetes treatments. An agreement with US-based Lexicon Pharmaceuticals centers on...
12.11.2015
- French drugmaker Sanofi has announced a new long-term strategy focused on four pillars including a reshaping of its portfolio, new drug launches, innovation in R&D and a...
